Patient medication of tyvaso 80MG - shipping to the baltimore VA medical center pharmacy.
Ended Awarded Last action
- Contract number
- 36C24526N0556
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,158
Award facts
- Contract value 100% obligated
- $33,158.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a delivery order to United Therapeutics Corp for the supply and shipping of Tyvaso 80mg medication to the Baltimore VA Medical Center Pharmacy. This $33,158.10 firm fixed-price delivery order, issued on April 28, 2026, with an ultimate completion date of May 4, 2026, was executed without a set-aside designation. The contract is performed under the company's parent master contract vehicle, the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), with the place of performance located in Bartlett, Tennessee.
This delivery order represents a routine pharmaceutical procurement under United Therapeutics' broader single-award Blanket Purchase Agreement with the VA National Acquisition Center, valued at $207.1 million through April 23, 2026. Tyvaso (treprostinil) inhalation solution is a specialized medication developed by United Therapeutics to treat pulmonary arterial hypertension, a rare and life-threatening condition affecting some veteran populations. As a biotechnology manufacturer headquartered in Silver Spring, Maryland, and registered as a self-certified small disadvantaged business, United Therapeutics serves as a critical supplier of specialized pharmaceutical products to the VA across multiple Veterans Integrated Service Networks nationwide, with this delivery order supporting the agency's mission to ensure reliable access to essential medical treatments for veterans.
Quick answers
Who was awarded contract 36C24526N0556?
36C24526N0556 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 28, 2026.
How much is contract 36C24526N0556 worth?
The government has obligated $33,158 on 36C24526N0556.
Is contract 36C24526N0556 an order under another contract?
Yes. 36C24526N0556 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0556 competed?
The extent of competition for 36C24526N0556 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award